Method for predicting the survival status and prognosis of esophageal cancer and a kit thereof

A method for predicting a survival rate and prognosis state of esophageal carcinoma patients, comprising:

• (a) providing a tissue sample from a case subject;
• (b) examining a expression level of CD14 antigen (CD14) or peptidase inhibitor 3 (PI3) in the case subject, comprising a RNA expression, a protein expression at a cellular level or a tissue level;
• and
• (c) comparing the expression level of CD14 antigen or peptidase inhibitor 3 (PI3) with a control subject;
• wherein the expression level of CD14 is higher than the control subject which means with a better survival rate and a better prognosis, and the expression level of PI3 is higher than the control subject, which means with a worse survival rate and a worse prognosis.